Michael Austwick
Director/Board Member chez VERONA PHARMA PLC
Profil
Michael Austwick is currently an Independent Non-Executive Director at Verona Pharma Plc.
Previously, he held positions as the Chief Executive Officer at Vectura Group Ltd., Vice President-Global Inhaled Respiratory at AstraZeneca, Inc., and Head-Global Respiratory Franchise at Novartis, Inc. He graduated from The University of Hull and completed his undergraduate degree at City University London.
Postes actifs de Michael Austwick
| Sociétés | Poste | Début |
|---|---|---|
| VERONA PHARMA PLC | Director/Board Member | 01/02/2024 |
Anciens postes connus de Michael Austwick
| Sociétés | Poste | Fin |
|---|---|---|
Novartis, Inc.
 Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a private company based in San Francisco. | Corporate Officer/Principal | - |
AstraZeneca, Inc.
 AstraZeneca, Inc. BiotechnologyHealth Technology Part of AstraZeneca PLC, AstraZeneca, Inc. manufactures vaccines. | Corporate Officer/Principal | - |
| VECTURA GROUP | Chief Executive Officer | - |
Formation de Michael Austwick
| The University of Hull | Graduate Degree |
| City University London | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| VERONA PHARMA PLC | Health Technology |
| Entreprise privées | 3 |
|---|---|
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a private company based in San Francisco. | Health Technology |
Vectura Group Ltd.
 Vectura Group Ltd. Pharmaceuticals: MajorHealth Technology Vectura Group Ltd. engages in the provision of pharmaceutical development. Its activities include research, development, and commercialization of novel therapeutic products. The company operates through the following segments: Switzerland, United Kingdom, Germany, United States of America, and France. Vectura Group was founded by David Anthony Gough in 1997 and is headquartered in Chippenham, the United Kingdom. | Health Technology |
AstraZeneca, Inc.
AstraZeneca, Inc. BiotechnologyHealth Technology Part of AstraZeneca PLC, AstraZeneca, Inc. manufactures vaccines. | Health Technology |
